This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Guangzhou Joyo Pharmatech Co., Ltd.. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Zhihua Ao: Innovator in Selective ROS1 Inhibition
Introduction
Zhihua Ao is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific kinases. His work focuses on creating innovative solutions for diseases associated with abnormal ROS1 kinase expression.
Latest Patents
Zhihua Ao holds a patent for a compound that acts as a highly selective ROS1 inhibitor. This patent, titled "Compound as highly selective ROS1 inhibitor and use thereof," discloses a class of compounds that selectively inhibit ROS1. The compounds are represented by a specific formula and include pharmaceutically acceptable salts. This innovation has the potential to lead to new treatments for diseases linked to abnormal ROS1 activity.
Career Highlights
Zhihua Ao is currently associated with Guangzhou Joyo Pharmatech Co., Ltd. His role at the company allows him to further his research and development efforts in the pharmaceutical industry. With a focus on innovative drug development, he continues to push the boundaries of what is possible in medical science.
Collaborations
Zhihua Ao collaborates with notable colleagues in his field, including Jianfei Wang and Guangwen Yang. These partnerships enhance his research capabilities and contribute to the advancement of their shared goals in drug development.
Conclusion
Zhihua Ao is a key figure in the realm of pharmaceutical innovation, particularly in the area of ROS1 inhibition. His contributions are paving the way for new therapeutic options and showcasing the importance of targeted treatments in modern medicine.